Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Stem cell exosomes may help treat hair loss by promoting hair growth.

Si Jun Zi Tang may slow aging by affecting specific cell signaling pathways.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Pantethine may boost the immune system's ability to fight sarcoma.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

QMSI is a valuable method for studying drug penetration in skin tissues.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

IL-17-producing γδ T cells help improve bone healing.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.